Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1' Substituted Carbon Nucleoside Analog. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111574523A reveals a novel one-step synthesis for 1'-substituted carbon nucleoside analogs, offering significant cost reduction and supply chain reliability for antiviral drug manufacturers.